Gebruikersprofielen voor "Span, P. "

span p

Geverifieerd e-mailadres voor radboudumc.nl
Geciteerd door 41359

Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy

TWH Meijer, JHAM Kaanders, PN Span, J Bussink - Clinical cancer research, 2012 - AACR
Radiotherapy, an important treatment modality in oncology, kills cells through induction of
oxidative stress. However, malignant tumors vary in their response to irradiation as a …

[PDF][PDF] Genomic actions of estrogen receptor?: what are the targets and how are they regulated?

WJ Welboren, FCGJ Sweep, PN Span… - Endocrine-related …, 2009 - researchgate.net
The estrogen receptor a (ERa) is a ligand-dependent transcription factor that regulates a large
number of genes in many different target tissues and is important in the development and …

[HTML][HTML] Molecular aspects of tumour hypoxia

SE Rademakers, PN Span, JHAM Kaanders… - Molecular …, 2008 - Elsevier
Hypoxia is an important feature of the microenvironment of a wide range of solid tumours. Its
critical role in radio- and chemoresistance and its significance as an adverse prognostic …

Signatures of mutational processes in human cancer

LB Alexandrov, S Nik-Zainal, DC Wedge… - Nature, 2013 - nature.com
All cancers are caused by somatic mutations; however, understanding of the biological
processes generating these mutations is limited. The catalogue of somatic mutations from a …

Landscape of somatic mutations in 560 breast cancer whole-genome sequences

S Nik-Zainal, H Davies, J Staaf, M Ramakrishna… - Nature, 2016 - nature.com
We analysed whole-genome sequences of 560 breast cancers to advance understanding of
the driver mutations conferring clonal advantage and the mutational processes generating …

HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures

H Davies, D Glodzik, S Morganella, LR Yates, J Staaf… - Nature medicine, 2017 - nature.com
Approximately 1–5% of breast cancers are attributed to inherited mutations in BRCA1 or
BRCA2 and are selectively sensitive to poly(ADP-ribose) polymerase (PARP) inhibitors. In other …

Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes

JMC Tubio, Y Li, YS Ju, I Martincorena, SL Cooke… - Science, 2014 - science.org
Introduction The human genome is peppered with mobile repetitive elements called long
interspersed nuclear element–1 (L1) retrotransposons. Propagating through RNA and cDNA …

[HTML][HTML] Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes

JB de Kok, RW Roelofs, BA Giesendorf… - Laboratory …, 2005 - Elsevier
For interpretation of quantitative gene expression measurements in clinical tumor samples,
a normalizer is necessary to correct expression data for differences in cellular input, RNA …

ChIP‐Seq of ERα and RNA polymerase II defines genes differentially responding to ligands

WJ Welboren, MA Van Driel… - The EMBO …, 2009 - embopress.org
We used ChIP‐Seq to map ERα‐binding sites and to profile changes in RNA polymerase II (RNAPII)
occupancy in MCF‐7 cells in response to estradiol (E2), tamoxifen or fulvestrant. …

[PDF][PDF] Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trial

GO Janssens, SE Rademakers… - Journal of clinical …, 2012 - academia.edu
Accelerated Radiotherapy With Carbogen and Nicotinamide for Laryngeal Cancer: Results of a
Phase III Randomized Trial Page 1 Accelerated Radiotherapy With Carbogen and …